| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Québec Quantique Enabling the Quebec Quantum Ecosystem | Catalyseur de l'écosystème quantique du Québec Québec Quantique regroupe les acteurs du Québec dans le secteur des sciences et technologies quantiques et travaille afin que le Québec soit reconnu comme un des grands développeurs de technologies quantiques dans le monde et que ces technologies, développées ici comme ailleurs, soient adoptées par des filières industrielles majeures du Québec d’ici 2030. _____________________ Québec Quantique brings together Quebec players in the field of quantum science and technology and is working to ensure that Quebec is recognized as one of the world's major developers of quantum technologies and … Type: | 10 | 2 | 8 | 4 |
 | MSD Italia [Automatic translation follows] We have always invented for one great purpose: Life We have always invented for one great purpose: Life MSD, known in the United States and Canada as Merck & Co., Inc., with headquarters in Kenilworth, (New Jersey, USA), is an American multinational leader in the pharmaceutical sector. For over 65 years in Italy and 130 in the world, we have revolutionized therapeutic paradigms for dozens of pathologies through the discovery of over 200 innovative molecules. Our mission is to discover, develop and make available innovative products and services that save and improve the lives of Patients around … Type: | 10 | 0 | 5 | 515 |
 | BaseClear BaseClear offers genomics expertise and consultancy to accelerate the understanding and use of microorganisms. Microbes have a huge potential to contribute to the solution of a large number of issues facing the modern world, ranging from antibiotic resistance and personal disease to poor crop yields and problems caused by global warming. For years, relatively little was known about the often-invisible world of microbes. However, the latest DNA technologies have provided tools to really see what is happening inside microbes and within microbial communities. This allow us to unravel the interactions between microbes and their hosts and environment. BaseClear, founded in … | 4 | 0 | 4 | 74 |
 | Selexis SA Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, … Type: | 2 | 0 | 0 | 35 |
 | American Society of Tropical Medicine and Hygiene (ASTMH) Advancing global health since 1903. Vision: A world free of tropical infectious diseases. Mission Statement: The American Society of Tropical Medicine and Hygiene, founded in 1903, is the largest international scientific organization of experts dedicated to reducing the worldwide burden of tropical infectious diseases and improving global health. We accomplish this through generating and sharing scientific evidence, informing health policies and practices, fostering career development, recognizing excellence, and advocating for investment in tropical medicine/global health research. ASTMH Values and Promotes Diversity The Society takes great pride in its diverse membership. Through its elected and appointed leaders, committee structure, awardees, Annual … Type: | 0 | 0 | 0 | 58 |
 | Sabin Vaccine Institute We are a global health non-profit on a mission to make vaccines more accessible, enable innovation & expand immunization The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit, 501(c)(3) organization with more than two decades of experience, Sabin is committed to finding solutions that last and … Type: | 3 | 0 | 3 | 108 |
 | Cohen Veterans Bioscience Advancing Brain Health Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics. Computational Modeling, Big Data Analytics, Predictive Disease Models, Post Traumatic Stress Disorder, Veterans Brain Health, Traumatic Brain Injury, Brain Health, Brain Trauma, Brain Research, and Neuroscience Type: | 1 | 0 | 1 | 26 |
 | Polypico Technologies Ltd Polypico Technologies Ltd. is a provider of innovative fluid dispensing technology Polypico Technologies Ltd. is a provider of innovative fluid dispensing technology based in Cork, Ireland. Founded in 2012, the privately owned company designs, and manufactures, fluid dispensing solutions for both Life Science and Industrial applications. Polypico technology enables new applications and possibilities and provides a new set of solutions for low volume fluid dispensing applications. Polypico’s core platform technology is based on a new innovation in non-contact ultra low volume acoustic dispensing. This platform technology brings new features, benefits and possibilities to applications where precision low volume fluid dispensing … Type: | 0 | 0 | 0 | 9 |
 | WCG We improve lives by accelerating research, together. WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG’s 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy … Type: | 1 | 0 | 1 | 1,270 |
 | Officinae Bio Dare to Discover: Precision DNA & RNA services to accelerate cell, gene, and RNA therapies development by Officinae Bio. At Officinae Bio we're developing a platform to support the future of biologically designed therapeutics. By developing breakthroughs in AI-enabled methodologies for nucleic manufacture we’re supporting pioneering research in Gene-modified Cell therapy, Gene therapy and RNA therapeutic research. DNA platform An automated platform for streamlined development of plasmids and libraries for viral vector and mRNA. RNA platform Our industry leading mRNA development and manufacturing solutions support rapid turnaround, advanced transcription capabilities and precision control over regulatory sequences design. Artificial Intelligence, RNA … Type: | 1 | 0 | 1 | 17 |
 | NuMedii NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases. Type: | 1 | 0 | 0 | 5 |
 | FairJourney Biologics FairJourney Biologics, your end-to-end antibody partner At FairJourney Biologics, cutting-edge science meets unparalleled expertise in antibody discovery and development. As your leading end-to-end solutions partner for antibody solutions, we are committed to revolutionizing your research and fast-tracking the success of your programs. With top-tier technologies and a team of seasoned researchers, we take pride in delivering high-quality, reliable antibodies tailored to meet your unique demands. Drawing upon over a decade of extensive expertise in antibody discovery and development, we have achieved remarkable results, with at least 14 antibodies having advanced to clinical stages as a direct outcome of these endeavours. … Type: | 1 | 0 | 0 | 278 |
 | Deciphera Pharmaceuticals Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com. | 0 | 0 | 0 | 403 |
 | Exelixis Every Exelixis employee is united in an ambitious cause: to transform science into new treatments that give cancer patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset. As a diverse, growing team, everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat. After operating in the challenging biotech sector for nearly three … Type: | 1 | 1 | 0 | 1,492 |
 | Diversity Alliance for Science The LIFE SCIENCE/ HEALTHCARE Organization to get involved in! Since 2008, Diversity Alliance for Science has been the pre-eminent networking organization for life science companies and diverse-certified suppliers to connect, collaborate and drive the value of diversity. Our networking events are about genuine connections and finding the best way to spark innovation through building business relationships on our diverse perspectives. Our suppliers and corporations build their bottom lines by keeping our shared goals in mind: all the work they produce contributes to making medicines, devices, and ideas that save lives. The best way to get to know our organization is … Type: | 7 | 0 | 7 | 10 |
 | Aidar Health, Inc. Empowering Personalized Healthcare Aidar Health, Inc., is a healthcare technology and digital medicine company reimagining today’s standards for clinical trials, chronic care management, and health monitoring. Our rapid medical assessment device, MouthLab, is a non-invasive, hand-held, home monitoring device that measures more than 10 vital medical parameters in 30 seconds. Sensor data is sent in real-time using LTE-M or Bluetooth to our secure HIPAA-compliant cloud, where our proprietary analytics system uses AI and machine learning algorithms to analyze, and generate actionable insights. This data can then be accessed through a physician portal, which allows for timely intervention and treatment modification … Type: | 4 | 0 | 3 | 14 |
 | QMENTA Medical imaging software solutions that improve outcomes for research, and clinical trials QMENTA is a Medical Imaging AI tech company that offers cloud native software solutions for imaging professionals and imaging clinical trials through one single platform. Our customizable platform, QMENTA Imaging Hub, integrates 5 solutions in one single system: An Imaging Cloud, A Smart Uploader, AI Imaging Biomarkers, Central Review, and an Imaging Management System, (Imaging EDC, query management, project management and reporting) removing fragmentation, delays, human errors. With our global cloud-based infrastructure powered by quality data and AI technology, your research teams will be able to integrate any … Type: | 3 | 0 | 0 | 41 |
 | pharma.be pharma.be is the federation of 130+ innovative pharmaceutical companies active in Belgium. pharma.be, the federation of the innovative biopharmaceutical industry in Belgium, represents over 128 companies and 42.000 employees active in human healthcare in Belgium. As a full partner of physicians, pharmacists, hospitals, governments and other stakeholders, pharma.be has the mission to promote better health care through therapeutic innovation in the domain of medicinal products for human and veterinary use. Therefore, the top priority is to ensure that patients have the fastest possible access to innovative medicines resulting from research and development. Twitter: https://twitter.com/pharmabe and @CarolineVen Website: www.pharma.be Pharmaceutical industry Type: | 10 | 1 | 10 | 51 |
 | Bordeaux Neurocampus The neuroscience Departement of Bordeaux University. 55 teams stuying brain function and pathologies. Bordeaux Neurocampus is the neuroscience Departement of the University of Bordeaux. It comprises pluridisciplinary research teams stuying brain function and pathologies. neuroscience, biology, and imaging | 8 | 2 | 4 | 37 |
 | Paratek Pharmaceuticals Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that … Type: | 1 | 0 | 1 | 314 |
 | Dragonfly Therapeutics, Inc. Dragonfly Therapeutics is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing therapies that use its novel multispecific antibody technology to harness the body's immune system to bring breakthrough treatments to patients. In addition to its wholly owned clinical assets, Dragonfly has a deep pipeline of wholly owned preclinical candidates discovered using its proprietary platform, as well as productive collaborations with Merck, AbbVie, Gilead and Bristol Myers Squibb in a broad range of disease areas. For more information, email info@dragonflytx.com. immuno-oncology Type: | 4 | 0 | 1 | 117 |
 | AVROBIO Clinical-stage lentiviral gene therapy company, powered by plato®. Our vision: bring personalized gene therapy worldwide Our vision is to bring personalized gene therapy to the world. We target the root cause of genetic disease by introducing a functional copy of the affected gene into patients’ own hematopoietic stem cells (HSCs), with the goal of durably expressing the therapeutic protein throughout the body, including the central nervous system. Our first-in-class pipeline includes clinical programs for Gaucher disease and Hunter syndrome, as well as a preclinical program for Pompe disease. Our proprietary plato® gene therapy platform is scalable for planned global commercialization. … Type: | 3 | 1 | 0 | 36 |
 | Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Arrowhead Pharmaceuticals is a clinical stage, Nasdaq listed (ticker ARWR) company developing medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, our therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Our RNAi-based therapeutics are at … Type: | 2 | 0 | 1 | 503 |
 | mAbxience From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South … Type: | 4 | 2 | 2 | 940 |
 | Deep 6 AI Deep 6 AI disrupts the clinical trial enrollment process by transforming the way researchers identify eligible patients. Using artificial intelligence and natural language processing to mine structured and unstructured patient data, DEEP 6 AI finds more, better-matching patients for trials in minutes, not months. Deep 6 AI works with some of the most prominent health systems, pharma companies, and CROs in the world --making the DEEP 6 platform a crucial step in their clinical research workflow and greatly accelerating patients’ access to clinical trials. DEEP 6 AI was founded in 2015 and is based in Pasadena, CA. healthcare analytics, unstructured … Type: | 4 | 0 | 2 | 56 |
 | TFS HealthScience Clinical Research Excellence TFS HealthScience is a global Contract Research Organization (CRO) that supports biotechnology and pharmaceutical companies throughout their entire clinical development journey. In partnership with customers, we build solution-driven teams working for a healthier future. Bringing together nearly 700 professionals, TFS delivers tailored clinical research services in more than 40 countries and supports customers with comprehensive solutions through three strong business models: Clinical Development Services (CDS), which provides full-service support at all stages of the clinical development process, Strategic Resourcing Solutions (SRS), which offers expert insourcing and targeted recruitment services, and Functional Services (FSP), to provide customers with … Type: | 0 | 0 | 0 | 800 |
 | Norwich Research Park Norwich Research Park is one of the 5 BBSRC Research and Innovation Campuses in the UK. It’s the only one in the UK with 4 research institutes, a university, and a hospital all on one single site. With strong research into grand challenges like food security and climate and a key focus on enterprise and community, the park is an ideal place for businesses to move to or collaborate with. The Park provides flexible laboratory and office accommodation and facilities for SMEs and growing businesses. For larger companies there are build-to-suit plots for the construction of bespoke laboratory and office … Type: | 5 | 2 | 4 | 15 |
 | Skyhawk Therapeutics We Use Small Molecules To Modify RNA Splicing Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that modify RNA expression. Our founders are leading experts in small molecule therapeutics development for RNA-based disease. Our first drug candidates are targeted toward cancers and neurological conditions. The company is based in Waltham, Massachusetts. For more information, please visit: www.skyhawktx.com. Type: | 1 | 0 | 1 | 68 |
 | Frequency Therapeutics Frequency Therapeutics is pioneering a new category in regenerative medicine. Frequency’s progenitor cell activation platform aims to restore human function by developing therapeutics that activate a person’s innate regenerative potential within the body. The Company’s lead preclinical program is designed to activate oligodendrocyte precursor cells with the goal of driving remyelination and potential functional recovery for individuals living with multiple sclerosis. Type: | 2 | 0 | 1 | 13 |
 | Outcomes4Me On a mission to democratize cancer patient care, one life at a time. Outcomes4Me is an AI-driven patient empowerment platform that helps cancer patients take a proactive approach to their care, gaining access to personalized, evidence-based treatment options and information. The company is on a mission to democratize healthcare by providing real-time, evidence-based clinical information to cancer patients, ensuring they can effectively navigate through their disease and improve their outcomes. In doing so, Outcomes4Me is working to promote health equity by generating deeper insights that improve care, and accelerating research and access to innovation. Based in Boston, Massachusetts, Outcomes4Me is … Type: | 3 | 0 | 2 | 32 |
 | Apollomics We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies. Apollomics is an innovative biotechnology company committed to the discovery and development of oncology combination therapies. With operations in both the U.S. and China, we believe we are well positioned to unlock synergies by leveraging the strengths of partnerships with other biotechnology companies in the East and the West. Since our founding in 2015, under the leadership of our experienced management team with in-depth knowledge and expertise of the evolving cancer treatment landscape, we have built a pipeline of ten (10) drug candidates … Type: | 1 | 0 | 1 | 30 |
 | Poseida Therapeutics, Inc. The Capacity to Cure Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. The Company's approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac® DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies as well as in-house … Type: | 2 | 0 | 2 | 331 |
 | Civica Rx Serving patients is a privilege that comes with significant responsibilities. Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q1 2024, we have provided over 155 million units of essential medicines to hospitals, enough to help treat nearly 70 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more … Type: | 1 | 0 | 0 | 163 |
 | UroGen Pharma UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from … Type: | 0 | 0 | 0 | 219 |
 | Organization for Rare Diseases India Collective voice of all persons living with rare disorders in India. National umbrella organization. Our Objectives Rare Diseases Patients Helpline and Helpdesk: ORDI runs a national rare disease hotline (+91 8892 555 000) to hear the needs of rare disease patients. ORDI will setup a dedicated helpdesk with the goal of enabling patients, access to information and resources to guide them through the process of diagnosing and dealing with the rare conditions affecting their health and quality of life. ORDI develops and maintains a public website, a patient portal, organizes awareness campaigns, and an annual rare disease conference in India. … Type: | 4 | 0 | 4 | 7 |
 | IUPAC Advancing the Worldwide Role of Chemistry The International Union of Pure and Applied Chemistry is the global organization that provides objective scientific expertise and develops the essential tools for the application and communication of chemical knowledge for the benefit of humankind and the world. IUPAC accomplishes its mission by fostering sustainable development, providing a common language for chemistry, and advocating the free exchange of scientific information. In fulfilling this mission, IUPAC effectively contributes to the worldwide understanding and application of the chemical sciences, to the betterment of humankind. Type: | 0 | 0 | 0 | 60 |
 | Association for Advancing Participatory Sciences We connect people who advance knowledge through research and monitoring done by, for, and with members of the public. The Association for Advancing Participatory Sciences (AAPS) is a member-driven organization that connects people from a wide range of experiences around one shared purpose: advancing knowledge through research and monitoring done by, for, and with members of the public. We are a repository of resources, best practices, and discussions. AAPS is also the home of the open-access, peer-reviewed journal Citizen Science: Theory and Practice, published by Ubiquity Press on behalf of the Association. Our annual conferences bring attention to cutting-edge and … Type: | 2 | 0 | 2 | 12 |
 |  KDBIO s.a.s. Distributor - cell culture products, hollow fiber cartridges KDBIO is actively seeking new life science distribution, sales and business development projects. Business Development, Sales, Marketing, and Distribution Type: | 0 | 0 | 0 | 1 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, development, … Type: | 6 | 0 | 0 | 449 |
 | Voyager Therapeutics, Inc. Breaking through barriers in gene therapy and neurology Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACERTM AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs … Type: | 3 | 0 | 2 | 198 |
 | Genovis We help Scientist build knowledge about their Biopharmaceuticals with our SmartEnzymes Genovis offers a unique range of rapid and easy to use enzymatic tools primarily for the biopharmaceutical industry. Available worldwide, these SmartEnzymesTM are supplied in innovative formats for the development, production and quality control of biological drugs such as monoclonal antibodies, ADCs, biosimilars and bispecifics. The Genovis SmartEnzymes are widely used for the digestion, de-glycosylation and conjugation of the target molecule and are an ideal companion to popular analytical techniques like LC-MS. Within the portfolio there are enzymes specific for: IgG digestion - FabRICATORTM, FabALACTICATM, GingisKHANTM, FabULOUSTM & FabRICATOR … Type: | 0 | 0 | 0 | 44 |
 | NovioSense BV NovioSense BV is a spin out company from Fraunhofer Gesellschaft and NovioTech BV based in Nijmegen. NovioSense is a wireless platform technology for non-invasive monitoring of disease biomarkers. The first sensor based on the NovioSense technology is a wireless non-invasive glucose sensor. Development is targeted at a clinical prototype for non-invasive continuous monitoring of glucose levels in tear fluid. Medical Devices, Sensor Development, Diabetes, and Medical Technology Type: | 0 | 0 | 0 | N/A |
 | NEOVACS Nous développons les thérapies de demain et investissons dans des sociétés innovantes en Biotech et Medtech Neovacs, a French Biotechnology company, develops therapeutic vaccines for the treatment of autoimmune, inflammatory diseases aand invests in innovative companies (Biotech and Medtech). active immunotherapies and therapeutic vaccine Type: | 2 | 0 | 1 | 26 |
 | Precigen Precigen (Nasdaq: PGEN) is a biopharmaceutical company advancing the next generation of gene and cell therapies. Precigen: Advancing Medicine with PrecisionTM Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated unique therapies toward clinical proof-of-concept and … Type: | 0 | 0 | 0 | 113 |
 | Sen-Jam Pharmaceutical We’re changing the way the world treats inflammation and the way the pharma industry treats humanity Join the revolution! We’re changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today → https://wefunder.com/senjam Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. It's time for a stronger, more resilient world, free of side-effects and filled with living remarkably Inflammation , Wellbeing, and Pain Relief Type: | 0 | 0 | 0 | 10 |
 | Lexicon Pharmaceuticals, Inc. At Lexicon, We Pioneer Medicines that Transform Patients' Lives Corporate Overview Lexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. The Genome: Our Source of Discovery We have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. Our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. We have integrated a series of recombinant DNA and chemistry technologies … Type: | 0 | 0 | 0 | 435 |
 | GlobalSkin The International Alliance of Dermatology Patient Organizations is a global voice for skin patient-centred research, advocacy & support. Type: | 0 | 0 | 0 | N/A |
 | Greater Gift Dedicated to increasing clinical research awareness and access to healthcare, especially among underrepresented groups. Join us in a powerful mission to give back to those who give the gift of health through clinical research. At Greater Gift, we celebrate and express gratitude to participants and contributors with meaningful gestures that make a difference. With donations from our partnerships, we show gratitude by donating to children in need by providing essential vaccines and nourishing food that transforms lives. We believe one good deed deserves another! Philanthropy, Nonprofit, and Clinical Research Type: | 3 | 0 | 2 | 9 |
 | coIMMUNE, Inc. coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity. Type: | 5 | 2 | 3 | 15 |
 | InCarda Therapeutics Pioneering inhaled medications for cardiovascular conditions InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF). Cardiovascular, Inhalation therapy, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Commercialization, Clinical Research, Pre-Clinical Research, and Regulatory Affairs Type: | 1 | 0 | 0 | 15 |
 | MindMed MindMed is a clinical-stage biopharma company developing novel products to treat brain health disorders MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the … Type: | 3 | 0 | 2 | 91 |
 | Unlearn.AI Advancing AI to eliminate trial and error in medicine. Advancing artificial intelligence to eliminate trial and error in medicine. Artificial Intelligence, Biotechnology, Pharmaceuticals, Machine Learning, Clinical Trials, Clinical Research, Computational Biology, Data Science, Biostatistics, Deep Learning, and Machine Learning Type: | 10 | 0 | 7 | 85 |
 | American Gene™ A cell & #genetherapy company with a #gene delivery platform to develop cures to #cancer #HIV #PKU. In Phase 1 trial for #HIVcure. CEO @JeffreyGalvin. Type: | 0 | 0 | 0 | N/A |
 | Centre for Infectious Disease Research in Zambia - CIDRZ For a Healthy Zambia The Centre for Infectious Disease Research in Zambia (CIDRZ) is an independent nonprofit Zambian company, registered as a nongovernmental organization that is committed to answering key research questions relevant to Zambia and the region. It supports the financial, and technical local ownership of high quality, complementary and integrated healthcare services within the Zambian public health system, and facilitates clinical, research and professional development training. Through close and on-going collaboration with the Government of the Republic of Zambia, Ministry of Health and other line Ministries, and by partnering with multiple leading local and international universities, CIDRZ ensures … Type: | 0 | 0 | 0 | 848 |
 | U.S. Military HIV Research Program At the Forefront of the Battle Against HIV MHRP is at the forefront of the battle against HIV. Our mission is to protect U.S. Service Members from HIV and improve global health by conducting research to develop an HIV vaccine, reduce new infections and advance strategies to induce long-term HIV remission. With an international network of research sites throughout Africa and Asia, the program’s growth and success has been achieved through a combination of strong science, careful development of research sites and partnerships with key research institutions in the U.S. and host countries. Since its inception in 1986, MHRP has … Type: | 2 | 1 | 1 | 35 |
 | Critical Path Institute (C-Path) Advancing Drug Development. Improving Lives. Together. Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona … Type: | 1 | 0 | 1 | 181 |
 | Vir Biotechnology, Inc. Powering the Immune System to Transform Lives Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden. Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis … Type: | 5 | 1 | 1 | 590 |
 | Orexo AB publ Improves lives for patients suffering from mental illness and substance use disorder 💚 Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2022 amounted to SEK 624 million, and the number of employees to 126. Orexo is listed on Nasdaq Stockholm's main list and is available as an … Type: | 2 | 1 | 1 | 113 |
 | VMS BioMarketing Leading Provider of Patient Engagement Solutions VMS BioMarketing is the leading provider of patient engagement solutions integrating human connection, advanced technology, and real-world data to deliver holistic support in a personalized environment. Leveraging 25+ years’ experience in patient engagement, our One VoiceTM model empowers biopharma teams to optimize the right mix of interventions for each patient. On behalf of our biopharma partners, we deliver 1M+ patient and healthcare provider engagements in person and virtually through our network of 800+ nurse educators nationwide. Our seasoned senior executive team is led by President and CEO Andrea Heslin Smiley, VMS has been certified … Type: | 0 | 0 | 0 | 228 |
 | Insmed Incorporated Insmed is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. The Company is dedicated to developing and bringing to market therapies that make a real difference in patients’ lives, while striving to understand and enhance the entire patient experience, from diagnosis and treatment to everyday living. Headquartered in Bridgewater, NJ, we are a rapidly growing company with offices in seven countries. Biotechnology, Orphan Disease State, Pharmaceuticals, Chronic Lung Infections, and Pulmonary Type: | 2 | 0 | 1 | 982 |
 | JFK Communications Provider of potent, long-acting and effective public relations medicine for a broad spectrum of life science PR ills JFK Communications provides content marketing and communications solutions for science, healthcare and technology organizations. We work clients in the life sciences, chemical, diagnostics, medical device, healthcare IT, nutraceutical and renewable energy industries. Our focus is on creating powerful stories that connect with prospects, customers and influencers, and communicating meaningful messages that influence behavior. Strategic Communications, Healthcare Communications, Inbound Marketing, Science and Technology Communications, Content development for science and technology, Medical writing, Technical communications, B2B Communications, Life Science Public Relations, and Healthcare PR Type: | 0 | 0 | 0 | 45 |
 | Medicines for Malaria Venture Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria Type: | 1 | 0 | 1 | 157 |
 | Crinetics Pharmaceuticals Discovering drugs for endocrine diseases and endocrine-related tumors. #acromegaly #crinetics #CarcinoidSyndrome This place is about more than a pharmaceutical career. It’s about making a real difference in the lives of patients. That’s why we’re here. That’s why you should maybe think about being here, too. Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of … Type: | 1 | 0 | 0 | 289 |
 | TAG TREATMENT ACTION GROUP INC Ensuring all people with HIV, TB, or HCV receive lifesaving treatment, care, and information. TAG TREATMENT ACTION GROUP INC is a Non-Profit based out of NEW YORK. TAG is an independent, activist, and community-based research and policy think tank committed to racial, gender, and LGBTQ+ equity; social justice; and liberation, fighting to end HIV, tuberculosis (TB), and hepatitis C virus (HCV). At TAG, we strive to reflect in our organizational composition and operations the values, principles, and rights for which we advocate externally. This includes a commitment to equity and justice, as well valuing diversity of experience, in our employment … Type: | 1 | 0 | 1 | 22 |
 | Science 37 Access More Patients. Enroll Faster. Clinical Research that Works for EveryoneTM Science 37’s mission is to accelerate clinical research by enabling universal trial access for patients. Through our solutions; the MetasiteTM and Patient Recruitment, we accelerate enrollment by expanding the reach of clinical trials to patients beyond the traditional site and rigorously qualifying patients prior to referring them to a traditional site. Our solutions are powered by a proprietary technology stack with in-house medical and operational experts that enhance quality through standardized workflows and best-in-class study orchestration. Patient Recruitment, Patient Qualification, Clinical Trial Enrollment, Clinical Trial Access, Site Conduct, Virtual … Type: | 4 | 0 | 4 | 352 |
 | Boundless Bio Unbound by convention, bound to save lives Boundless Bio is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence. When DNA in cancer cells comes off chromosomes, “extrachromosomal DNA (ecDNA),” it becomes unbound and unwound, thereby enabling numerous copies of cancer-causing genes, driving cancer cells to grow and allowing them to resist treatment. At Boundless Bio, we are counterattacking this ecDNA phenomenon with boundless innovation and boundless energy to develop powerful new cancer medicines that eliminate cancer cells’ ability to employ ecDNA to survive. Our Culture: At Boundless, you’ll … Type: | 2 | 0 | 1 | 79 |
 | Symphogen Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, operates within in research, early clinical stages and CMC biologics development from research to market. Supporting Servier’s commitment to improve patients health and the R&D strategy within oncology and immune-oncology - Symphogen’s strategic focus is to apply our streamlined and effective antibody platform and capabilities in the discovery and early development of highly differentiated antibodies. The aim is to develop novel compounds either as combination or as stand-alone therapies for difficult to treat cancers. oncology, immune-evasive, and AXL Type: | 0 | 0 | 0 | 195 |
 | Mitsubishi Tanabe Pharma America We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, … Type: | 4 | 0 | 1 | 246 |
 | TG Therapeutics, Inc. TG is a biopharmaceutical company focused on the development of novel treatments for B-cell diseases. TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS). Biotechnology, hematological malignancies, non-Hodgkin's lymphoma, multiple sclerosis, b-cell diseases, ublituximab, and umbralisib Type: | 0 | 0 | 0 | 353 |
 | Global Institute for Disease Elimination (GLIDE) We are a global health institute focused on accelerating the elimination of preventable infectious diseases of poverty. The Global Institute for Disease Elimination aims to be an innovative leader accelerating progress towards disease elimination to alleviate suffering and improve human lives. With an inter-disciplinary approach, the institute both advances the global understanding of elimination science and supports countries to translate knowledge into action in order to eliminate infectious diseases globally. neglected tropical diseases, malaria, polio, global health, capacity building, disease elimination, development, and NTDs Type: | 1 | 0 | 1 | 17 |
 | IDDO Pioneers in generating new research evidence from existing data since 2009 - putting equity for global researchers at the forefront. Type: | 0 | 0 | 0 | N/A |
 | Replimune Replimune's mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response. Replimune is pioneering the development of novel oncolytic immunotherapies. We imagine a world where cancer is a curable disease. | 2 | 0 | 1 | 316 |
 | Medisafe, a STERIS Company Medisafe is now STERIS Medisafe is now STERIS. Type: | 0 | 0 | 0 | 45 |
 | Max Delbrück Center Discovery for tomorrow's medicine The Max Delbrück Center for Molecular Medicine (MDC) conducts basic biomedical research with the aim of transferring research findings as soon as possible into clinical applications. Here the focus is on the diagnosis and treatment of diseases as well as on prevention. Research at the MDC is divided into four main areas: cardiovascular and metabolic diseases, cancer, diseases of the nervous system and systems biology. The MDC cooperates closely with the Charité - Universitätsmedizin Berlin and with the Berlin universities. Together with the Charité, the MDC has founded the Berlin Institute of Health (BIH). Imprint/Impressum: https://www.mdc-berlin.de/imprint … Type: | 1 | 0 | 1 | 813 |
 | TRON-Mainz Science in Translation - We put inspiration into practice, finding viable solutions to complex challenges. Our mission is to turn scientific breakthroughs into progress for patients. TRON is a non-profit research institute that pursues new diagnostics and drugs for the treatment of cancer and other diseases with a high medical need. We aim to bridge the gap between fundamental science at universities and market-oriented research in the pharmaceutical industry. We turn innovative scientific concepts into treatments ready for clinical testing, thereby accelerating the translation of discoveries into new diagnostics and therapies for patients. We focus our transdisciplinary competencies in genomics … Type: | 2 | 0 | 2 | 142 |
 | MannKind Corporation Our mission is to give people control of their health and the freedom to live life. MannKind Corporation (Nasdaq: MNKD) focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. We are committed to using our formulation capabilities and device engineering prowess to lessen the burden of diseases such as diabetes, pulmonary arterial hypertension (PAH) and nontuberculous mycobacterial (NTM) lung disease. Our signature technologies – dry-powder formulations and inhalation devices – offer rapid and convenient delivery of medicines to the deep lung where … Type: | 4 | 0 | 3 | 540 |
 | Amalgam Rx Enabling better healthcare decisions. In the provider workflow. In patients’ everyday lives. Amalgam helps patients and providers make the best decisions possible - in the provider workflow and in patients’ everyday lives. Through a suite of EHR Solutions and a modular SaMD platform Amalgam enables the leading life sciences companies, health plans, and provider organizations to collaboratively deliver better care. Today, Amalgam's algorithms and applications support nearly 10 million patients across 4 continents and have helped providers make over 50 million decisions. For more information on how Amalgam's regulated digital products, EHR solutions, or 10 billion RWE data points can … Type: | 4 | 0 | 2 | 56 |
 | Sonata Therapeutics Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences … Type: | 6 | 0 | 6 | 57 |
 | Intravacc Innovating vaccines to reduce human diseases. Part of Utrecht Science Park Bilthoven Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies. As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials … Type: | 2 | 0 | 0 | 103 |
 | Arvinas Leading the way in targeted protein degradation therapeutics Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and “undruggable” targets, the company has four investigational clinical-stage … Type: | 3 | 0 | 1 | 441 |
 | Radius Health, Inc. We are a biopharmaceutical company dedicated?to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other. Type: | 0 | 0 | 0 | 313 |
 | Supernus Pharmaceuticals, Inc. We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals Inc. We market our products in the United States through our own specialty sales force and seek strategic collaborations with other pharmaceutical companies to license our products outside the United States. We market Qelbree® (viloxazine extended-release) for the treatment of attention deficit/hyperactivity disorder (ADHD) in … | 0 | 0 | 0 | 707 |
 |  UNIVERCELLS Univercells is a global life sciences company making biologics available to everyone. We operate as a campus of start-ups: five businesses solving different parts of the same puzzle - meeting global demand for bioproduction. Because it is not enough for a drug to exist. To change the world it must be accessible to everyone. Each division of affiliates operates a different part of the healthcare value chain, through a distinct business model: Exothera is a Contract Manufacturing and Development Organization (CDMO) for biologicals, mainly vaccines and viral vectors, with GMP production facilities in Belgium and offering process development and optimization … Type: | 3 | 1 | 2 | 174 |
 | PHIRI - Population Health Information Research Infrastructure for COVID-19 “Pulling resources, knowledge, and fostering collaboration to help humanity combat COVID-19 and future pandemics.” The Population Health Information Research Infrastructure for COVID-19 is a European mechanism that aims to facilitate and support data-driven population health research and exchange of best practices to support decision making. PHIRI has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101018317. Type: | 4 | 0 | 4 | 1 |
 | Airfinity Ltd The disease forecasting company, helping you track, predict, and simulate to achieve better disease outcomes. Airfinity tracks, simulates, and predicts population level disease outcomes in real time to inform decisions that can increase the global life span. Specialising in infectious diseases, Airfinity works with the entire life science ecosystem. Our suite of proprietary surveillance tools and forecast models analyse and predict disease outcomes. Spanning over 150 viral, bacterial and fungal pathogens, we use advanced meta science, statistics, epidemiology and machine learning solutions to dynamically understand true disease prevalence and underlying outcome drivers. By combining this with expert analysis and commentary … Type: | 14 | 0 | 14 | 100 |
 | Global Health Innovative Technology (GHIT) Fund The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, … Type: | 2 | 0 | 2 | 21 |
 | IgniteData Shaping the Future of Clinical Trial Data IgniteData’s Archer technology is transforming the way hospitals and research sites transfer data for clinical trials. EHR-to-EDC data transfer provides fast, accurate patient data for clinical studies, significantly reducing the requirement for laborious data transcription and source data verification (SDV). pharmaceutical, NHS, Electronic Health Records, healthcare data, Clinical Research, Clinical Trials, Clinical Studies, Site Data Verification, biopharma, biopharmaceutical, EHR, EMR, EHR2EDC, interoperability, DigiHealth, medtech, software, life science, healthcare, eClinical, and TrialTech Type: | 5 | 0 | 4 | 16 |
 | ReCode Therapeutics Powering the next wave of genetic medicines through superior delivery ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. RNA Therapies, Genetic Medicines, Non-Viral Lipid Nanoparticles, Genetic Respiratory Disease, Cystic Fibrosis, Primary Ciliary Dyskinesia, and Biotechnology Type: | 4 | 1 | 4 | 127 |
 | Canadian Partnership Against Cancer A pan-Canadian partnership for better cancer outcomes. The Canadian Partnership Against Cancer is an independent organization funded by the federal government to accelerate action on cancer control for all Canadians. Our model is unique to addressing cancer, cooperating and collaborating across jurisdictions and organizations. Our efforts are collectively focused on the long-term objectives of reducing the incidence of cancer, reducing the likelihood of dying from cancer and improving the quality of life of those affected by cancer. Visit www.partnershipagainstcancer.ca to find out more. Type: | 0 | 0 | 0 | 187 |
 | Phathom Pharmaceuticals Going beyond to advance treatments for patients with acid-related disorders Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging. We are looking for … Type: | 0 | 0 | 0 | 394 |
 | BioCentriq Manufacturing Partner for Cell and Gene Therapy Process Development and Clinical Production BioCentriq is an established, highly collaborative, global cell therapy CDMO. The company has been successfully manufacturing drug products for use in human clinical trials since 2022. In June of 2023, BioCentriq launched its LEAPTM Advanced Therapy Platform which helps cell therapy developers move from contract to clinic in as short as six months. With industry recognized scientists, engineers, analysts, and manufacturing specialists, established quality systems and modern infrastructure, BioCentriq is a proven strategic partner for the development and manufacturing of both autologous and allogeneic cell therapy products. The … Type: | 1 | 0 | 1 | 74 |
 | PsychoGenics Discover Your Next Breakthrough PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into … Type: | 0 | 0 | 0 | 149 |
 | Century Therapeutics, Inc Harnessing the power of adult stem cells to develop curative therapies for cancer and autoimmune diseases Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune and inflammatory diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the … Type: | 2 | 0 | 0 | 180 |
 | SOLTI [Automatic translation follows] Innovative Breast Cancer Research SOLTI is a leading group in clinical cancer research in Spain. With a consolidated track record of more than 25 years, its main activity focuses on the design and execution of translational-based clinical studies within the academic field. Her interest has been focused on breast cancer, but she opens her scope to other tumors. SOLTI has accumulated experience of 80 clinical trials and more than 30 underway and is made up of 480 researchers in a network of 100 centers between Spain, Portugal and Ireland, coordinated by a central office in which a … Type: | 5 | 0 | 5 | 111 |
 | Faculté de Pharmacie Montpellier [Automatic translation follows] Created more than 200 years ago, the Faculty of Pharmacy of Montpellier is among the largest in France with more than 2,300 students and nearly 400 teaching-researcher staff, teachers, researchers and administrative and technical staff. Anchored in its territory, the faculty gives an essential dimension to Montpellier pharmaceutical sciences by offering courses responding to scientific and societal challenges, and by contributing to the development of research in areas of excellence such as chemistry, the environment, agro-sciences... Type: | 8 | 4 | 5 | 106 |
 | National Foundation for Infectious Diseases (NFID) Healthier lives for all through the effective prevention and treatment of infectious diseases Founded in 1973, the National Foundation for Infectious Diseases (NFID) is a non-profit 501(c)(3) organization dedicated to educating and engaging the public, communities, and healthcare professionals about infectious diseases across the lifespan Infectious Diseases and Education Type: | 1 | 0 | 1 | 13 |
 | Agencja Badań Medycznych [Automatic translation follows] Our mission: "Through research to health" Medical Research Agency (ABM) - is a state legal entity responsible for the development of scientific research in the field of medical and health sciences. The agency is an important tool for creating an innovative health care system in Poland. The establishment of the Medical Research Agency is a response to the unsatisfactory level of financing for clinical trials and the need to provide institutional support for financing analyzes and scientific research in health care. Its creation will ensure the development of medical and health sciences and will contribute to the … Type: | 5 | 0 | 4 | 97 |
 | Cerba Research Transforming Research, Advancing Health Together At Cerba Research we provide world-class clinical research to help life science companies successfully develop the predictive and precision medicines of the future and help people live healthier lives. We are committed to delivering the next generation of healthcare by transforming research and advancing health together. We support you with industry-leading excellence in oncology, virology, vaccine development, immunology, and cell and gene therapy, together with world-class deep specialty testing, from next generation sequencing to flow cytometry, molecular diagnostics, IHC & and spatial Omics, and bioinformatics. We are committed to helping you deliver the next generation … Type: | 3 | 2 | 1 | 643 |
 | Gyroscope Therapeutics Vision for Life: Developing gene therapies and delivery technologies for eye diseases. About Gyroscope Therapeutics, a Novartis company: Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022. Gyroscope’s lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness. GT005 has received Fast Track designation from the U.S. … Type: | 1 | 1 | 0 | 49 |
 | Velocity Clinical Research, Inc. Delivering high-quality clinical trial data and patient care with unprecedented efficiency. Velocity is the world’s leading organization of fully integrated clinical research sites. With 90 sites and more than 220 investigators, Velocity partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, diagnostics, and combination products that could improve human health and wellbeing. Velocity offers unified research site solutions to efficiently provide the right patients, investigators, and research staff for clinical trials across the U.S. and Europe. The company also operates a technology hub in India, where it is unlocking a new era in clinical research by developing … Type: | 3 | 0 | 3 | 1,004 |
NGO, Think-tanks, Ed, & Culture